Joakin Mori, PhD
Postdoctoral Associate (previously held)
Boston University Chobanian & Avedisian School of Medicine
Hematology & Oncology

Websites
favorite icon LinkedIn


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Mori JO, Platz EA, Lu J, Brame A, Han M, Joshu CE, De Marzo AM, Meeker AK, Heaphy CM. Longer prostate stromal cell telomere length is associated with increased risk of death from other cancers. Front Med (Lausanne). 2024; 11:1390769.View Related Profiles. PMID: 38895181; PMCID: PMC11184561; DOI: 10.3389/fmed.2024.1390769;
     
  2. Mori JO, Keegan J, Flynn RL, Heaphy CM. Alternative lengthening of telomeres: mechanism and the pathogenesis of cancer. J Clin Pathol. 2024 Jan 18; 77(2):82-86.View Related Profiles. PMID: 37890990; PMCID: PMC11450735; DOI: 10.1136/jcp-2023-209005;
     
  3. Mori JO, Elhussin I, Brennen WN, Graham MK, Lotan TL, Yates CC, De Marzo AM, Denmeade SR, Yegnasubramanian S, Nelson WG, Denis GV, Platz EA, Meeker AK, Heaphy CM. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer. Nat Rev Urol. 2024 May; 21(5):258-273.View Related Profiles. PMID: 37907729; PMCID: PMC11058122; DOI: 10.1038/s41585-023-00827-x;
     
  4. Jafari N, Chen A, Kolla M, Pompa IR, Qiu Y, Yu R, Llevenes P, Ennis CS, Mori J, Mahdaviani K, Halpin M, Gignac GA, Heaphy CM, Monti S, Denis GV. Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic disease. Adv Cancer Biol Metastasis. 2022 Dec; 6.View Related Profiles. PMID: 36644690; PMCID: PMC9836031; DOI: 10.1016/j.adcanc.2022.100073;
     
  5. Mori JO, White J, Elhussin I, Duduyemi BM, Karanam B, Yates C, Wang H. Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patients. Front Oncol. 2022; 12:928357. PMID: 36033462; PMCID: PMC9399459; DOI: 10.3389/fonc.2022.928357;
     
  6. Husain K, Villalobos-Ayala K, Laverde V, Vazquez OA, Miller B, Kazim S, Blanck G, Hibbs ML, Krystal G, Elhussin I, Mori J, Yates C, Ghansah T. Apigenin Targets MicroRNA-155, Enhances SHIP-1 Expression, and Augments Anti-Tumor Responses in Pancreatic Cancer. Cancers (Basel). 2022 Jul 25; 14(15). PMID: 35892872; PMCID: PMC9331563; DOI: 10.3390/cancers14153613;
     
  7. Mori JO, Shafran JS, Stojanova M, Katz MH, Gignac GA, Wisco JJ, Heaphy CM, Denis GV. Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteins. Prostate. 2022 Jun; 82(10):1005-1015.View Related Profiles. PMID: 35403746; PMCID: PMC11134172; DOI: 10.1002/pros.24351;
     
  8. Ma W, Du H, Zhang M, Mori J, Ren X, Wang H, Zhang X. One-Step Synthesis of Tunable Zinc-Based Nanohybrids as an Ultrasensitive DNA Signal Amplification Platform. ACS Appl Mater Interfaces. 2020 Jan 15; 12(2):2983-2990. PMID: 31854969
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 8 publications over 4 distinct years, with a maximum of 4 publications in 2022

YearPublications
20201
20224
20231
20242

Contact for Mentoring:

72 E. Concord St
Boston MA 02118
Google Map

Download vCard

Mori's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (34) concept(s)
_
Co-Authors
See all (10) people
_
Similar People
See all (60) people
_
Same Department
Search Department